Cholesterol emboli syndrome occurring after administration of tissue plasminogen activator.
Baldwin
Sharolyn Hoover
SH
Keesler Medical Center, KAFB, MS, USA.
Musa
John
J
D017700:Embolism, Cholesterol / Q000139:chemically induced*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator